Fundraising Fox
/Companies
Sign in

WinSanTor

San Diego, US · Delaware corporation · 1 known investors

Find your way into WinSanTor

Each arrow is one introduction. Sign up to fill in the first one.

72 people can intro you to Stan

Ask Richard Heyman to introduce you to Stan Kim

You →Richard · together at Salk Institute for Biological Studies →Stan

Sign up to find every way you can get introduced to WinSanTor

  • Your email: who you already know at WinSanTor, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the WinSanTor team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Winsantor is a clinical-stage biotechnology company developing treatments for peripheral neuropathies, including diabetic peripheral neuropathy and chemotherapy-induced peripheral neuropathy. The company is currently advancing its lead drug candidate, WST-057, through Phase 2 clinical trials in Canada.

BiotechHealthtechMedical Devices

Founders & leadership

SKStan Kim
Stan KimCEO and Co-FounderStan Kim is the Executive Officer and Director of WinSanTor, a clinical-stage biotechnology company developing treatments for peripheral neuropathies. He has previously founded multiple technology and healthcare companies.
NC
Nigel CalcuttNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$782.9K disclosed across 1 round · 2017

▶$782.9KraisedNov 2017 · 16 investors · Pharmaceuticals
Officers, directors & promoters on the filing
  • Stan KimExecutive Officer, Director
  • Nigel CalcuttDirector
Offering amount
$2M
Amount sold
$782.9K
Minimum investment
$20K
First sale
May 2017
Incorporated
Corporation, Delaware
Federal exemptions
04
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

UbieUbie provides a free AI-powered symptom checker that generates a personalized report on possible causes of a user's symptoms and guidance on when to see a doctor, based on a short questionnaire developed with doctors. The consumer-facing digital health service operates in Japan, the United States, and other countries.
DoctronicDoctronic builds an AI system trained on peer-reviewed medical evidence to provide 24/7 medical triage and consultation, achieving 99.2% alignment with board-certified clinicians. The platform serves patients seeking instant healthcare guidance with no insurance requirement, anonymity, and HIPAA compliance.
OsmosisOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.

Companies working in the same space as WinSanTor.

Frequently asked questions

What does WinSanTor do?
Winsantor is a clinical-stage biotechnology company developing treatments for peripheral neuropathies, including diabetic peripheral neuropathy and chemotherapy-induced peripheral neuropathy. The company is currently advancing its lead drug candidate, WST-057, through Phase 2 clinical trials in Canada.
Who are WinSanTor's investors?
WinSanTor's investors include Thynk Capital.
How much funding has WinSanTor raised?
WinSanTor has disclosed $782.9K raised across 1 round.
Where is WinSanTor headquartered?
WinSanTor is headquartered in San Diego, US.